Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

17.91
Delayed Data
As of Oct 16
 +0.05 / +0.28%
Today’s Change
4.03
Today|||52-Week Range
22.00
+64.16%
Year-to-Date

Today’s Trading

Previous close17.86
Today’s open17.83
Day’s range17.57 - 18.28
Volume496,400
Average volume (3 months)942,119
Market cap$739.2M
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)+17.75%
Earnings growth (this year)+43.61%
Earnings growth (next 5 years)--
Revenue growth (last year)+124.95%
P/E ratioNM
Price/Sales4.49
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-1.72-15.68%
ADROAduro Biotech Inc+0.25+2.70%
EGRXEagle Pharmaceutical...-1.00-1.94%
ENTAEnanta Pharmaceutica...-0.60-1.24%
Data as of 3:59pm ET, 10/16/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$82.7M
Annual profit (last year)-$142.1M
Net profit margin-171.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Operating Officer
Marcio Souza
Corporate headquarters
South Plainfield, New Jersey

Forecasts